Dr. Yufei Wang received a 2022 KCA Trailblazer Award for her research on “Design of CAIX Targeted Fine-Tuned Immune Restoring Safe (FIS) CAR-T Cell Therapy for Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)”. Dr. Wang…

Dr. Sheldon Holder received a 2022 KCA Trailblazer Award for his research on the “Exploration of the causes and effects of increased PIM1 kinase activity in renal cell carcinoma”. Dr. Holder is a physician-scientist at…

Dr. Erin Tagai received a 2022 KCA Psychosocial Focus Award for her research on “Improving patient-reported outcomes for renal cancer patients on active surveillance.” Dr. Tagai is an Assistant Research Professor at Fox Chase Cancer…

Dr. David Braun received a 2022 KCA Trailblazer Award for his research on “Dissecting the immunobiology of chromophobe renal cell carcinoma using single-cell transcriptomics.” Dr. Braun is a medical oncologist and an Assistant Professor of…

Dr. Srinivas Viswanathan received a 2022 KCA Trailblazer Award for his research on “Advancing a Cell Surface Therapeutic Target in Translocation Renal Cell Carcinoma. Dr. Viswanathan is a medical oncologist at the Dana-Farber Cancer Institute….

Dr. Pooja Ghatalia received a 2022 KCA Trailblazer Award for her research on “Comparison of immune microenvironment between patients of African and European ancestry with renal cell carcinoma.” Dr. Ghatalia is a medical oncologist and…

Dr. Nazli Dizman received a 2022 KCA Trailblazer Award for her research on the “Impact of CBM588 on metabolomic profile in patients with metastatic renal cell carcinoma (mRCC)”. Dr. Dizman is an internal medicine resident…